Veracyte | VCYT - Stock


Veracyte reported $20.55M in Stock for its fiscal quarter ending in December of 2025.





Stock Change Date
Agilent USD 1.06B 34M Dec/2025
Anika Therapeutics USD 18.79M 2.5M Dec/2025
Arrowhead Research USD -173.08M 173.08M Dec/2024
Bruker USD 1.2B 21.7M Sep/2025
Heron Therapeutics USD 54.57M 2.33M Dec/2022
Illumina USD 564M 26M Dec/2025
Intrexon USD 287K 68K Dec/2022
Karyopharm Therapeutics USD 4.04M 72K Dec/2025
Laboratory Of America USD 534.7M 13.2M Dec/2025
Ligand Pharmaceuticals USD 9.13M 2.77M Dec/2025
Myriad Genetics USD 30.6M 1000K Dec/2025
Rigel Pharmaceuticals USD 13.3M 2.88M Sep/2025
Roche Holding CHF 7.6B 9M Jun/2025
Siemens EUR 10.26B 906M Sep/2025
Sonic Healthcare AUD 208.83M 3.83M Jun/2024
Thermo Fisher Scientific USD 5.43B 320M Dec/2025
Veracyte USD 20.55M 219K Dec/2025
Waters USD 572.37M 570K Dec/2025